微信公众号

官网二维码

中国癌症防治杂志

• 论文 • 上一篇    下一篇

华蟾素配合放疗治疗鼻咽癌近期疗效观察

梁平;蒙富斌;王洪乾;   

  1. 广西中医学院附属瑞康医院放疗科;广西玉林市红十字会医院放疗科;
  • 收稿日期:2009-06-25 修回日期:2009-06-25 出版日期:2009-06-25 发布日期:2009-06-25

Preliminary result from cinobufacin combined with radiotherapy on nasopharyngeal carcinoma

LIANG Ping~1,MENG Fu-bin~2,WANG Hong-qian~2.   

  1. (1 Department of Radiotherapy,Ruikang Hospital of Guangxi Traditional Chinese Medicine University,Nanning Guangxi 530011,China;2 Department of Radiotherapy,Yulin Red Cross Hospital,Yulin Guangxi 537000,China
  • Received:2009-06-25 Revised:2009-06-25 Online:2009-06-25 Published:2009-06-25

摘要: 目的探讨华蟾素在鼻咽癌放射治疗中的作用。方法2004年5月至2006年5月对我院68例鼻咽癌随机分别采用放疗联合华蟾素(研究组)和单纯放疗(对照组)治疗,放疗方法相同,放疗过程中急性反应按RTOG/EORTC标准记录,治疗结束和结束后3个月评价疗效。结果放疗结束时研究组和对照组有效率(RR)分别为85.29%(29/34)和73.53%(25/34),两组差异无统计学意义(x~2=0.810,P=0.368)。对获部分缓解(PR)以上效果的患者进一步分析,其中放疗结束时研究组和对照组淋巴结转移灶完全缓解率(CR)分别为69.0%和45.6%(P=0.0627);放疗后3月CR分别为82.8%和52.0%(x~2=4.549,P=0.0329)。口咽黏膜反应2级以上对照组有30例,研究组21例,组间比较差异有统计学意义(x~2=6.472,P=0.039);皮肤反应、血小板和血红蛋白指标无明显差异。结论华蟾索对提高鼻咽癌淋巴结转移灶控制率和减轻放疗急性反应都有一定的效果,但其远期疗效有待进一步随访及研究。

关键词: 华蟾素, 鼻咽肿瘤, 肿瘤/放射疗法

Abstract: Objective To explore the therapeutic effects of cinobufacin combined with radiotherapy on nasopharyngeal carcinoma (NPC).Methods 68 NPC patients from May 2003 to May 2005 were assigned randomly into the study group and control group.Both groups were treated with the same radiotherapy,but the treatment in study group was combined with cinobufacin. Acute side effects of radiotherapy were assessed according to the RTOG(radiation therapy oncology group) standard,and the curative effects were evaluated at the end of the treatment and at the third month after treatment Results At the end of treatment,the local response rates in the study group and the control group were 85.29%(29/34) and 73.53%(25/34) respectfully, the difference between the two groups was not significant(x~2=0.810,P = 0.368).But the result from further analysis on the patients with the responses more than partial remission showed the complete remission rates of lymph node metastasis in study group and control group were 69.0%and 45.6%respectively at the end of treatment(P =0.0627),and 52.0%and 82.8%respectively at the third month after treatment(x~2 =4.549,P = 0.0329).The side effects of acute skin-mucosal that serious more than grade 2 was significantly different(x~2 =6.472,P =0.039) between the study group(10 cases) and control group(21 cases).There was no statistically significant difference between the two groups on skin response,platelet and hemoglobin decreases.Conclusions Cinobufacin can enhance the control rate of lymph node metastasis and reduce the incidence of acute side effects of radiotherapy.Further follow-up study on its long-term effect is necessary.

Key words: Cinobufacin, Nasopharyngeal neoplasm, Radiotherapy